The increased expression of PD-1 attenuates the T-cell response and promotes cancer immune escape by the interaction between PD-1 and its ligand proteins, namely programmed death ligand-1 (PD-L1) and programmed death ligand-2 (PD-L2) that are expressed on cancer cell surfaces [32]. This evidence concerns the gene PDCD1LG2 and cancer.